Canadian firms fear release of "confidential" info under new law
This article was originally published in Scrip
Executive Summary
The Canadian parliament has passed a bill that will give the health minister greater powers to order safety recalls of medicines and devices and to require labelling changes and post-marketing studies. The bill will also introduce a little more transparency in the area of clinical trial data publication.